Navigation Links
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012
Date:3/13/2013

per diluted share, in the fourth quarter of 2011. In the fourth quarter of 2011, the Company recorded a loss from change in fair value of warrants of $3.1 million, while no such loss was recorded in the same quarter of 2012.

Fiscal Year 2012 Financial PerformancesTotal sales in 2012 were $184.8 million, an increase of 20.7% from $153.1 million in 2011. Excluding foreign exchange influence, the increase in sales was primarily attributable to a mix of price and volume increases in plasma-based products, as well as a substantial increase in sales of placenta polypeptide products.

During 2012, most of the Company's approved products recorded price increases. The general price increases for the human albumin products and immunoglobulin product group (other than human hepatitis B immunoglobulin products) were primarily attributable to strong market demand and a shortage of supply following the closure of several plasma collection stations in Guizhou in 2011.

During 2012, human albumin products and human immunoglobulin for intravenous injection ("IVIG") products remained the largest two sales contributors.

  • As a percentage of total sales, human albumin product revenue was 44.6% in 2012 as compared to 54.5% in 2011. Sales volume of human albumin products declined 9.2% over the year.
  • As a percentage of total sales, IVIG revenue was 39.0% in 2012 as compared to 32.3% in 2011. Sales volume of IVIG products increased by 33.6% over the year, mainly due to increased market demand and the Company's ability to ship more product as a result of increased inventory levels built up in the later part of 2011 in anticipation of the demand increase.
  • Cost of sales increased by 27.9% to $58.8 million in 2012 from $46.0 million in 2011. Cost of sales as a percentage of total sales was 31.8%, as compared to 30.1% in 2011. Volume and percentage increases in cost of sales were mainly due to increased sales activities and increased raw p
    '/>"/>

    SOURCE China Biologic Products, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
    2. CentraState and Freehold Radiology Group train physicians from China
    3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
    4. ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report
    5. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
    6. China Biologic Products Reports Higher Results for the First Quarter 2012
    7. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
    8. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
    9. China Botanic Attends 67th PHARMCHINA Fair
    10. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
    11. China Botanic Attends the 111th China Import and Export Fair
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... MOUNTAIN VIEW, Calif. , Sept. 30, 2014 /PRNewswire/ ... today, which integrates with HealthKit in iOS 8 and ... with their doctors. The app harnesses native iOS technologies ... patients to maintain a robust connection with their doctors ... wearable health devices and the data they collect is ...
    (Date:9/30/2014)... NEW YORK , Sept. 30, 2014 ... growth stage. Both established medical-device providers as well as ... Eastern European region, while simultaneously looking at ways to ... this sector. Using distributors is one of the effective ... the medical devices distribution market in Eastern European and ...
    (Date:9/30/2014)... The report based on "Nutraceutical ... Growth and Forecast, 2007 - 2017," elaborated by Transparency ... billion in 2012 and is further expected to reach ... of 7.3% from 2012 to 2017. Nutraceutical ... especially to prevent chronic diseases that may occur to ...
    Breaking Medicine Technology:HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4
    (Date:9/30/2014)... September 30, 2014 Two revolutionary procedures now ... treatment of gum disease a far less painful and ... , “If you’ve ever felt electric shock waves surge through ... a cold beverage, it’s possible you already know the impact ... is a general dentist in West Palm Beach, and a ...
    (Date:9/30/2014)... 30, 2014 (HealthDay News) -- Medicare should cover low-dose ... risk for the disease, a coalition of more than ... which includes the Lung Cancer Alliance, the Society of ... Cancer Society and the American Society of Clinical Oncology, ... the U.S. Centers for Medicare & Medicaid Services (CMS). ...
    (Date:9/30/2014)... has made progress in reducing the stigma associated with ... post-traumatic stress disorder, but more improvement is still needed, ... efforts of both the Defense Department and the Veterans ... members still do not seek needed care for ... effort to promote treatment as a way to reduce ...
    (Date:9/30/2014)... ANN ARBORThe discovery of a gene mutation that causes ... development of drugs that block the rapid, unstoppable cell ... at the University of Michigan and the U-M Health ... devastating disease dyskeratosis congenita, in which precious hematopoietic stem ... DC age prematurely and are prone to cancer and ...
    (Date:9/30/2014)... 30, 2014 FDA-approved injectable dermal ... acid) are used in several procedures that are ... patients, but are primarily used for wrinkle treatment ... particular, these fillers are being used as popular ... smoother skin in the hands. (1) (2) Dr. ...
    Breaking Medicine News(10 mins):Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Disease decoded: Gene mutation may lead to development of new cancer drugs 2Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 2Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 3Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 4
    ... sexual adaptation shows that evidence is building for what ... appearing in Current Directions in Psychological Science, physical and ... males have evolved to deliver their sperm more effectively ... people are familiar with the idea of animals competing ...
    ... spider, a cousin to the well-known black widow, is increasingly ... is belongs to a group that is officially known as ... as "fiddleback" spiders or "violin" spiders because of the violin-shaped ... and thorax). ,The spiders are generally found in ...
    ... Union Minister of State for Environment and Forests, Shri ... century just as information technology dominated the last century. ... Consultative Committee of the Ministry of Environment and Forests, ... on Genetic Engineering Approval Committee has been vacated today ...
    ... In line with Ranbaxy Laboratories aggressive international expansion ... has solidified the acquisition of Be-Tabs Pharmaceuticals ... ,The deal is valued at R500 million ... fifth largest generic pharmaceutical company in South Africa. ...
    ... the champagne bottles which contained the weed killer that poisoned ... to him by a person well known to him-bowling coach Mustaq ... the team manager Talat Ali was witness to this. ... and Talat Ali knew the person or persons who handed over ...
    ... Concern over side effects of various drugs could be ... profile recalls like Vioxx, the osteoarthritis drug. ... Boston researchers at the Tufts-New England Medical Center. ... of Health Affairs, researchers compared half a dozen risky ...
    Cached Medicine News:Health News:Louisiana Residents Warned Against Brown Recluse Spiders 2Health News:Biotechnology Will Dominate The 21st Century 2Health News:Ranbaxy Labs Extends Roots in South Africa 2Health News:Ranbaxy Labs Extends Roots in South Africa 3Health News:Drug Risks Must Be Balanced Against Benefits, Researchers 2
    ... single use loading unit (SULU), the EEA™ ... staples., ,Immediately after staple formation, a ... excess tissue, thus creating a circular anastomosis. ... handles firmly as far as they will ...
    ... The Scantibodies Calcitonin Immunoassay is a ... of calcitonin. Two different goat polyclonal antibodies ... affinity chromatography to be specific for well-defined ... the quantitative determination of Calcitonin in human ...
    ... in the parafollicular C-cells of the thyroid ... The major action of calcitonin is to ... activity, resulting in decreased mobilization of calcium ... evident in conditions associated with high levels ...
    Calcitonin RIA Kit...
    Medicine Products: